Products

Signal Tracker Data Platform Data Enrichment API Intelligence desk

Solutions

Inward Investment & Aftercare Deal Origination Executive Search Corporate Development Signal-Based Outbound Competitive Intelligence Funding Signals Competitor Monitoring For Sales Teams For Founders For Agencies For Investors

Explore

Companies Live Signals Markets Trends

Resources

Signal Checker Blog Integrations FAQ Contact Pricing
Login Book a demo
ClonOrgan logo — Pioneering the future of organ transplantation with human-co...

ClonOrgan

Pioneering the future of organ transplantation with human-compatible organs grown from gene-edited pigs through a comprehensive R&D platform since 2005.

Founded 2005 Series A Total: $16.97M Biotechnology, Health Care

General Information

Company Name ClonOrgan
Founded Year 2005
Industries Biotechnology, Health Care
Funding Stage Series A
Social

Get notified when ClonOrgan moves

Funding, new markets, leadership changes, hiring surges — one e-mail, only when something happens.

Free · no account needed

About ClonOrgan

ClonOrgan is a biotechnology company that has been pioneering the future of organ transplantation since its establishment in 2005. The company's slogan, "Pioneering the future of organ transplantation with human-compatible organs grown from gene-edited pigs through a comprehensive R&D platform," encapsulates its groundbreaking approach. ClonOrgan focuses on xenotransplantation and has devised a method to humanize pig cells, thereby enabling the growth of organs compatible with human transplantation. The last investment of $6.97M Series A came from Royal Sea Capital on 03 September 2021. ClonOrgan offers a comprehensive R&D platform that spans from the cultivation of gene-edited pigs to preclinical testing and breeding. The company's mission is to address the severe shortage of organs for clinical transplantation and establish the future's organ production hub. Located in Chengdu, Sichuan, ClonOrgan is at the forefront of addressing this critical medical need. In the rapidly evolving fields of biotechnology and healthcare, ClonOrgan's innovative approach and recent investment from Royal Sea Capital demonstrate the confidence and potential in the company's vision to revolutionize organ transplantation.

Taxonomy: Xenotransplantation, Organ transplantation, Gene editing, Regenerative medicine, Medical technology, Research and development, Pig organs, Human-compatible organs, Preclinical testing, Biomedical innovation

Funding Rounds & Investors (2)

View All
Funding Stage Amount Investors Lead Investors Date
Series A •••••• 1 •••• •••• 05 Jul 2024
Series A •••••• 1 •••• •••• 03 Sep 2021

ClonOrgan Alternatives & Competitors

ClonOrgan vs
Johannus Orgelbouw
Johannus Orgelbouw The Netherlands

The Sound of Excellence

26 employees
Manufacturing, Music
ClonOrgan vs
ScubaTx Limited
ScubaTx Limited United Kingdom

Let’s Breathe Life into the Organ Transplant Market

Seed
11 employees
Health Care, Life Sciences
ClonOrgan vs
eGenesis
eGenesis United States

Restoring life after organ failure.

Series D
151 employees
Biopharma, Biotechnology
Compare ClonOrgan vs eGenesis
Also compare with: ClonOrgan vs Precise Bio Precise Bio

FAQ About ClonOrgan

Pioneering the future of organ transplantation with human-compatible organs grown from gene-edited pigs through a comprehensive R&D platform since 2005.
ClonOrgan was founded in 2005.
ClonOrgan operates in the following industries: Biotechnology, Health Care.
ClonOrgan has completed 2 funding rounds, raising a total of $16.97M. The latest funding stage is Series A.
Top alternatives and competitors to ClonOrgan include Johannus Orgelbouw, ScubaTx Limited, eGenesis, LifeLink Foundation , Precise Bio. These companies operate in related industries and serve comparable markets. You can compare them side by side on Bounce Watch.
ClonOrgan and Johannus Orgelbouw are both companies in similar industries. Compare their funding, team size, growth signals, and market position on Bounce Watch to see which one fits your needs.

Don't just browse. Track.

Signal Tracker monitors ClonOrgan and millions of companies for funding rounds, hiring surges, product changes, and 40+ signal types — so you never miss an opportunity.

See how it works

One analytics cookie (Google Analytics). Cookie Policy